Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
Sign Up to like & getrecommendations! Published in 2017 at "Experimental hematology"
DOI: 10.1016/j.exphem.2017.06.007
Abstract: Acute myeloid leukemia (AML) develops when there is a block in differentiation and uncontrolled proliferation of myeloid precursors, resulting in bone marrow failure. AML is a clinically, morphologically, and genetically heterogeneous disease, and biological differences… read more here.
Keywords: cd33; adult childhood; acute myeloid; myeloid ... See more keywords